Celltrion Pharm, Inc. (KOSDAQ:068760)
South Korea · Delayed Price · Currency is KRW 68,100
-1,600 (-2.30%)
At close: Feb 6, 2026
Celltrion Pharm Market Cap
Celltrion Pharm has a market cap or net worth of 3.02 trillion as of February 6, 2026. Its market cap has increased by 22.07% in one year.
Market Cap
3.02T
Enterprise Value
n/a
Revenue
274.73B
Ranking
n/a
PE Ratio
116.74
Stock Price
68,100.00
Market Cap Chart
Since February 3, 2006, Celltrion Pharm's market cap has increased from 66.37B to 3.02T, an increase of 4,452.32%. That is a compound annual growth rate of 21.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 3.02T | 17.41% |
| Dec 30, 2025 | 2.57T | 4.33% |
| Dec 30, 2024 | 2.47T | -35.41% |
| Dec 28, 2023 | 3.82T | 44.48% |
| Dec 29, 2022 | 2.64T | -43.45% |
| Dec 30, 2021 | 4.67T | -46.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yuhan | 7.79T |
| Hanmi Pharm. | 7.00T |
| Hanall Biopharma | 2.48T |
| Daewoong Pharmaceutical | 1.88T |
| GC Biopharma | 1.88T |
| Chong Kun Dang Pharmaceutical | 1.15T |
| Ildong Pharmaceutical | 1.13T |
| Daewoong | 969.11B |